Company / EPS (Diluted)
DaVita EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$7.42
FY2025
5-year range
$5.27 / $8.90
FY2021-FY2025
Trend
+26.8%
vs FY2024
Sector context
#22 of 159
Health Care
What the data says
DaVita's eps (diluted) of $7.42 is higher than 86% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $0.92 in FY2020 to $8.90 in FY2023.
Based on SEC 10-K filings.
7.42 in FY2025 with a 5-year CAGR of +51.8%. Top quartile in the Health Care sector.
Declined from $8.90 to $7.42 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- +51.8%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 159This company $7.42 Sector average $1.56
▼
+376.7% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 26.8% year-over-year.
- Ranks #22 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.42 | +26.8% |
| FY2024 | $5.85 | -34.3% |
| FY2023 | $8.90 | +41.0% |
| FY2022 | $6.31 | +19.7% |
| FY2021 | $5.27 | +472.8% |
| FY2020 | $0.92 | -73.5% |
| FY2019 | $3.47 | -19.1% |
| FY2018 | $4.29 | +23.6% |
| FY2017 | $3.47 | -19.1% |
| FY2016 | $4.29 | +243.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026